South Africa Pharmaceuticals & Healthcare Report Q3 2013 - New Market Study Published
South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market. The country currently boasts the largest medicines market on the continent by value, with a double-digit increase in expenditure expected in the medium and long terms. However, we caution there are downside risks to our bullish outlook. These stem from increasing government pressure to contain costs in the relatively small private sector (currently a gold mine for drugmakers); and long, inefficient approval times -...
View full press release